Drug Information Association Conference To Explore Global Pharmacovigilance And Risk Management Strategies And Regultory Frameworks

The field of medical product safety continues to grow in complexity, with both clinical trial safety and post-marketing pharmacovigilance becoming ever more critical in the development and marketed use of medical products. In response, the Drug Information Association (DIA) will host

More: continued here

Filed under: Pharma Industry on October 28th, 2008